Viewing StudyNCT00287079



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00287079
Status: COMPLETED
Last Update Posted: 2013-12-27
First Post: 2006-02-02

Brief Title: A Prospective Study Looking at the Use of Rebif in Subjects With Clinically Isolated Syndrome
Sponsor: Merck KGaA Darmstadt Germany
Organization: Merck KGaA Darmstadt Germany

Organization Data

Organization: Merck KGaA Darmstadt Germany
Class: INDUSTRY
Study ID: IMP 26222
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Merck KGaA Darmstadt Germany
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
EMD Serono Canada Inc INDUSTRY